LIG1 loss exposes a therapeutic vulnerability in triple-negative breast cancer
Loss of one copy of the DNA ligase I (LIG1) gene in triple-negative breast cancers (TNBC) with TP53 mutations confers resistance to chemotherapy, but researchers at Baylor College of Medicine and collaborating institutions ...
Jul 17, 2026
0
34









